SCHEMBL22796039

SCHEMBL22796039

Brc1ccc(N2C[C@H]3CCC[C@H]3C2)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
PDE10A Q9Y233 2/20 0.45
SMPD3 Q9NY59 2/20 0.41
AKR1C3 P42330 1/20 0.41
ACACB O00763 1/20 0.40
CXCR3 P49682 1/20 0.37
GRM1 Q13255 2/20 0.35
PANK3 Q9H999 1/20 0.35
OGA O60502 1/20 0.35
AR P10275 1/20 0.34
DYRK1A Q13627 1/20 0.33
LCAT P04180 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22796041 1.00 GRIN2D (0.45) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL29782885 0.86 GRIN2D (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL17610078 0.86 GRIN2D (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15856219 0.82 KMT5A (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL15856218 0.82 HRH4 (0.50) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL929461 0.81 CHRNA7 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL930487 0.81 CHRNA7 (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL3581854 0.81 PDE10A (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22796105 0.80 GRIN2D (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22795923 0.80 PDE10A (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020248972-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF JS INNOPHARM (SHANGHAI) LTD (CN) 2020-12-17 WO disclosed